கேத்தரின் ஸ்சுழ்தே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேத்தரின் ஸ்சுழ்தே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேத்தரின் ஸ்சுழ்தே Today - Breaking & Trending Today

Progenity, Inc. (PROG) Q1 2021 Earnings Call Transcript


Progenity, Inc. (PROG) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Progenity, Inc. (NASDAQ: PROG)
Operator
Good afternoon everyone. Welcome to the Progenity first-quarter 2021 earnings call. [Operator instructions] And later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator instructions] And I will now turn the call over to Robert Uhl, managing director with Westwicke ICR, Progenity s investor relations firm.
Robert Uhl
Managing Director
Thank you, operator. Good afternoon and welcome to Progenity s first-quarter 2021 financial results conference call. Joining me on the call are Dr. Harry Stylli, chairman and chief executive officer; and Eric d Esparbes, chief financial officer. ....

United States , Ji Nam , Catherine Schulte , Andrew Cooper Raymond James , Raymond James , Catherine Schulte Baird , Piper Sandler , Andrew Cooper , Steven Mah , Janet Zhang , Steven Mah Piper Sandler , Robert Uhl , Dan Leonard , Colitis Foundation , Ventures Program , Motley Fool Progenity Inc , Progenity Inc , American College Of Gastroenterologists , Wells Fargo , Motley Fool Progenity , Call Transcript , Motley Fool Logo , Harry Stylli , Motley Fool Stock Advisor , Stock Advisor , Foolish Best ,

PerkinElmer Inc (PKI) Q1 2021 Earnings Call Transcript


PerkinElmer Inc (PKI) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
PerkinElmer Inc (NYSE: PKI)
Operator
Good day and thank you for standing by. And welcome to the Q1 2021 PerkinElmer Earnings Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. Please be advised that today s conference is being recorded. [Operator Instructions]
I will now like to hand the conference over to your speaker today, Bryan Kipp, Vice President of Investor Relations. Please go ahead.SPONSORED:
10 stocks we like better than PerkinElmer ....

United States , United Kingdom , Matt Sykes , Catherine Schulte , Tom Peterson Baird , Prahlad Singh , Asia Pacific , Vijay Kumar , Chris Lobianco Cowen , Patrick Donnelly , Patrick Donnelly Citi , Bryan Kipp , Daniel Brennan , Matt Sykes Goldman Sachs , Oxford Immunotec , Steve Willoughby , Doug Schenkel , Vijay Kumar Evercore , Dan Leonard , Josh Waldman , Broad Institute , Painting Consortium , Motley Fool Perkinelmer Inc , Goldman Sachs , Perkinelmer Inc , Mike Ryskin Bank ,

Exact Sciences (EXAS) Q1 2021 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Exact Sciences first-quarter 2021 earnings call. [Operator instructions] I would now like to hand the conference over to your speaker today, Mr. Erik Holznecht, senior financial analyst. Sir, please begin.
Erik Holznecht
Senior Investor Relations Associate
Thank you, Brent. And thanks to all of you for joining us for Exact Sciences first-quarter 2021 conference call. On the call today are Kevin Conroy, the company s chairman and CEO; and Jeff Elliott, our chief financial and chief operating officer. Exact Sciences issued a news release earlier this afternoon detailing our first-quarter financial results. ....

United States , Catherine Schulte , Dan Arias , Doug Schenkel Cowen , Jamie Foxx , Erik Holznecht , Brandon Couillard Jefferies , Dan Brennan , Johns Hopkins , Kevin Conroy , Brandon Couillard , America Merrill Lynch , Doug Schenkel , Brian Weinstein William Blair , Brian Weinstein , Jeff Elliott , William Blair , Derik De Bruin Bank , Dan Arias Stifel Financial Corp , Company Analyst , Exact Sciences , Exact Science , Investor Relations , Chief Executive , Chief Operating , Precision Oncology ,